SRB Tablet
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Samchundang Pharmaceutical Co., Ltd.
MFDS item code 201501538 · Approved 2015.03.24
This product's status changed to Expired on 2025.03.24. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (e.g., ulcers, gastritis, and gastroesophageal reflux disease); prevention of Mendelson syndrome
This medication is used to treat various gastrointestinal diseases including gastric and duodenal ulcers, gastritis, and gastroesophageal reflux disease. It is also effective in conditions where excessive gastric acid secretion occurs, such as Zollinger-Ellison syndrome. It is used to prevent ulcers that may occur after surgery and ulcers caused by NSAIDs (non-steroidal anti-inflammatory drugs). Prior to anesthesia, it may be administered to prevent Mendelson's syndrome. In summary, this drug is used to improve ulcer and inflammation symptoms associated with various gastrointestinal diseases.
(Tablets) ○ Adults The usual dose is 2 tablets per dose, taken orally twice daily in the morning and at bedtime, without regard to meals. 1) Gastric and duodenal ulcers Take 2 tablets per dose twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by taking 4 tablets per dose twice daily in the morning and at bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs and for combination therapy to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug use usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although the healing period may occasionally be longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets per dose once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Take 2 tablets per dose twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets per dose 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets per dose 3 times daily; the dose may be increased as needed. For severe disease, up to 6 g of ranitidine daily may be administered as directed by a doctor. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 2 tablets per dose twice daily. 5) Premedication (prevention of Mendelson syndrome) Administer 2 tablets per dose 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets per dose on the night before surgery.
This medication should not be used in patients undergoing dialysis or with severely impaired kidney function. Additionally, it should not be administered to patients who have had allergic reactions to this drug or its components, have a history of acute porphyria, have undergone upper gastrointestinal surgery, are pregnant or may become pregnant, are premature infants or neonates, or are on a potassium-restricted diet. Caution is advised when administering this drug to patients with impaired liver function or a history of drug allergy, elderly patients, or those with a history of kidney dysfunction. If taking non-steroidal anti-inflammatory drugs, especially elderly patients or those with a history of peptic ulcer, should be monitored regularly. This medication may mask symptoms of gastric cancer; thus, patients over middle age with gastric ulcers or newly developed or changed dyspeptic symptoms should verify that they do not have a malignant disease before using it. Patients with Helicobacter pylori-positive gastric or duodenal ulcers require eradication therapy. In severe ICU patients, there is a risk of gastric stone formation, so caution is necessary, and patients with hypophosphatemia should be cautious as the aluminum component of this medication may hinder phosphate absorption. Patients with swallowing difficulties have also been reported to experience respiratory complications after taking this drug, so caution is needed. While taking this medicine, serious allergic reactions such as anaphylactic shock can rarely occur, so if symptoms appear, patients must stop taking the medication immediately and seek medical assistance. Adverse reactions such as skin rash, urticaria, angioedema, fever, bronchospasm, hypotension, and chest pain may occur, and if such symptoms occur, administration should be discontinued. Blood tests may show rare occurrences of leukopenia, thrombocytopenia, or abnormalities in liver function, and if symptoms present, testing should be conducted, and administration should be stopped if necessary. Abnormal heart rhythms, gastrointestinal symptoms (nausea, vomiting, constipation, diarrhea), and neurological symptoms (dizziness, drowsiness, confusion, convulsions) have also been reported, and healthcare professionals should be consulted in case of any abnormal symptoms. Rarely, symptoms such as myalgia, arthralgia, skin rashes, hair loss, stomatitis, and skin itching may occur. It is advisable not to take this medication for prolonged periods, and during treatment, regular blood tests and liver and kidney function tests should be performed to monitor any abnormalities. Elderly patients, those with chronic pulmonary diseases, diabetes, and patients with compromised immune systems may have an increased risk of pneumonia when taking this medication, so caution is needed. If dizziness or drowsiness occurs after taking the medication, it is advisable to avoid driving or operating machinery. This medication may interact with other drugs, so especially when taken with anticoagulants or certain antibiotics, anticonvulsants, it is important to inform healthcare providers, and dose adjustments or adjustments in administration intervals may be required. If sucralfate is included, it may interfere with the absorption of some antibiotics or other medications, so it is advisable to have an interval of at least 2 hours between administrations. Women who are pregnant or may become pregnant should not use this medication, and nursing mothers should also avoid it as the drug may be passed through breast milk. The safety and efficacy of this medication in children have not been established, so it is preferable not to use it in children. This drug may cause false positive results in urine protein tests, so it is recommended to use the sulfosalicylic acid method when conducting urine protein tests. In case of overdose, emergency measures such as vomiting or gastric lavage may be needed, and in severe cases, blood dialysis may be required. This medication may reduce gastric acid secretion and increase the proliferation of bacteria in the gastrointestinal tract, thus requiring periodic examinations, including eye examinations, during long-term use.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air exposure and kept at a temperature between 1°C and 30°C at room temperature. Proper storage will help maintain the effectiveness of the medication.
White round film-coated tablet
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Samchundang Pharmaceutical Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.